KemPharm selects KP1077 for idiopathic hypersomnia as lead SDX candidate

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

KemPharm selects KP1077 for idiopathic hypersomnia as lead SDX candidate

To read the full story on Seeking Alpha, click here.

KemPharm (NASDAQ:KMPH)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more KemPharm Charts.

KemPharm (NASDAQ:KMPH)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more KemPharm Charts.

KemPharm Inc News

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Monday 29 April 2024 (1 month ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Thursday 11 April 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 10 April 2024 (2 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Tuesday 9 April 2024 (2 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Thursday 4 April 2024 (2 months ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Thursday 4 April 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 2 April 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 1 July 2023 (11 months ago) • Edgar (US Regulatory)

More KemPharm Inc News Articles

Nu Infra Fic Incent Em I...

3x Long Arm Etp

MSCI China ESG Leaders S...

XS2682326132 20281003 40...

XS2723536467 20271229 62...

Caisse Depots Et Consign...

Croda Int.5.9pf

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions